A 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP of the European Pharmacopoeia monograph is often referred to as a 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE Certificate of Suitability (COS). The purpose of a 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE to their clients by showing that a 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP has been issued for it. The manufacturer submits a 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP (COS) as part of the market authorization procedure, and it takes on the role of a 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP holder for the record. Additionally, the data presented in the 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE DMF.
A 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE suppliers with CEP (COS) on PharmaCompass.